Carl Zeiss Meditec AG (ETR:AFX – Get Free Report) shares dropped 3% on Friday . The company traded as low as €27.04 and last traded at €27.34. Approximately 268,173 shares changed hands during trading, an increase of 184% from the average daily volume of 94,405 shares. The stock had previously closed at €28.20.
Carl Zeiss Meditec Price Performance
The company has a debt-to-equity ratio of 29.43, a quick ratio of 2.47 and a current ratio of 2.43. The stock has a market cap of $2.55 billion, a price-to-earnings ratio of 14.61, a price-to-earnings-growth ratio of 2.83 and a beta of 1.33. The business’s fifty day simple moving average is €27.01 and its 200 day simple moving average is €27.78.
About Carl Zeiss Meditec
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data.
See Also
- Five stocks we like better than Carl Zeiss Meditec
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
